World-Class Leadership

SENIOR LEADERSHIP

IMG_20200624_105741
Dr. Olga Kubassova, PhD
Chief Executive Officer
Life Science Innovator, Venture Partner and Bio-Pharma Drug Development Strategist

Chief Excecutive Officer of IAG, with expertise in actively managing innovation in life science companies, asset positioning, strategy and capital.

Jan Lundberg_TB Alliance Board of Directors
Dr. Jan Lundberg, MD, PhD
Chair of Scientifc Advisory Board
Novel Drug Discovery and Development

Chair of IAG’s Scientifc Advisory Board and expert in global pharmaceutical R&D, developing treatments in immunology, neurology and oncology.

prostate-cancer-iag
Dr. Jamshid Dehmeshki, PhD
Chief Technology Officer
Expert in Imaging, AI and Machine Learning in Drug Development

IAG’s Chief Technology Officer and AI Professor, recognized expert in imaging strategies and artificial intelligence to optimize data management and data analytics.

archimed-christophe-2_3
Christophe Berthoux, MD
Chairman
Biotech and Pharma Drug Development Strategy

Chairman of IAG and operating partner of ArchiMed, recognized commercial leader in clinical research sector, investor and strategist.

MichaelClark
Michael Clark, PMP
Chief Operating Officer
Building Teams and Scalling Capabilities to Deliver Global Scale Imaging Clinical Trials

IAG’s COO and drug development veteran with 20+ years of experience growing teams and scaling operations.

Himoff
Jon Himoff
Chief Product Officer
Leading Product Design and Engineering organization with P&L ownership and customer focus.

IAG’s CPO and technology leader with 20+ years of experience developing products and scaling companies globally.